Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene – Expands Global IP in Precision Oncology Platform
Press Releases
Hoth Therapeutics, Inc.  
April 17, 2025

Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene – Expands Global IP in Precision Oncology Platform

Patent Grant Strengthens Hoth's RNA Therapeutics Pipeline with Broad Claims Covering KIT-Targeted Antisense Oligomers for Oncology and Immunology Applications

avatar profile Olean Times Herald

Olean Times Herald


Local & Social